PDE4A and chronic obstructive pulmonary disease: Moreover, PDE4 inhibitors are used as anti-inflammatory drugs for the treatment of inflammatory disorders, such as roflumilast for chronic obstructive pulmonary disease (COPD) and apremilast for psoriasis and psoriatic arthritis.